buprenorphine/naloxone

Developed for: substance-related disorder
Investigated by: Duke University · National Institute on Drug Abuse (NIDA) · The Emmes Company, LLC

today NCT03248947 · Ph 0

2018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 0	NCT03248947	Mar 2018 → Jun 2019	substance-related disorder	Duke University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	buprenorphine/naloxone	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03248947 ↗